Darwin Global Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-452,040
Closed -$10.3M 10
2024
Q2
$10.3M Sell
452,040
-21,160
-4% -$481K 1.19% 7
2024
Q1
$17.9M Buy
+473,200
New +$17.9M 2.39% 9